Aptevo Therapeutics Inc.
Q3 2024 13F Holders
Symbol
APVO
CUSIP
03835L306
Type
Equity
Class
COM
Num filers
20
Total reported value, excl. options
$231 k
Compare 2024 Q3 to
2024 Q2
2024 Q1
Manager
Report Date
Value ($000)
Shares
Option Type